Open Protocols

This person has no open protocols at the present moment.

Closed Protocols

This person has no closed protocols at the present moment.

Publications

No publications found at the present moment.

Interests

Identifying genetic and non-genetic risk factors for lung cancer and related phenotypes; inequities in lung cancer screening

Dr. Melinda Aldrich’s research is focused on understanding why there are differences in lung cancer risk and survival among different racial/ethnic populations. She and her lab focus on identifying genetic and non-genetic risk factors for lung cancer and related phenotypes, such as pulmonary function. They are building an African American collaborative study to investigate mechanisms driving lung cancer racial disparities. Her lab works with the Southern Community Cohort Study, ILCCO, and the Vanderbilt DNA biobank (BioVU) and other collaborators to investigate lung cancer. They are also investigating the genetics of immunotherapy treatment among lung cancer patients. Additional ongoing work includes investigating the genetics of chronic obstructive pulmonary disease and the population genetics of African Americans and other admixed populations. Dr. Aldrich’s research also focuses on addressing inequities in lung cancer screening, particularly for underserved populations. Her research has been used in key guidelines from the U.S. Preventive Services Task Force.

To update protocols, publications, biomarkers, or science data, please contact the Data Management and Coordinating Center.

Site

Vanderbilt -Ingram Cancer Center

Degree(s)

M.P.H., Ph.D.

Email

melinda.adlrich@vumc.org

Person ID

4333

EDRN Title

Co-Investigator

Note

To update contact information, please visit the Data Management and Coordinating Center .